Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
PDA Journal of Pharmaceutical Science and Technology
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
PDA Journal of Pharmaceutical Science and Technology

Advanced Search

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • Follow pda on Twitter
  • Visit PDA on LinkedIn
  • Visit pda on Facebook
OtherResearch

The effect of formulation, process and method variables on the reconstitution time in dual chamber syringes

Tobias Werk, Imke Sonja Ludwig, Hanns-Christian Mahler, Joerg Luemkemann, Joerg Huwyler and Mathias Hafner
PDA Journal of Pharmaceutical Science and Technology June 2016, pdajpst.2015.006387; DOI: https://doi.org/10.5731/pdajpst.2015.006387
Tobias Werk
1 F. Hoffmann-La Roche Ltd;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: tobias.werk@roche.com
Imke Sonja Ludwig
1 F. Hoffmann-La Roche Ltd;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: imke_sonja.ludwig@roche.com
Hanns-Christian Mahler
2 Lonza AG;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joerg Luemkemann
1 F. Hoffmann-La Roche Ltd;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joerg Huwyler
3 University of Basel;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mathias Hafner
4 University of Heidelberg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • References
  • Info & Metrics
  • PDF
Loading

Article Information

pdajpst.2015.006387
DOI 
https://doi.org/10.5731/pdajpst.2015.006387
PubMed 
27325597

Published By 
Parenteral Drug Association (PDA)
Print ISSN 
1079-7440
Online ISSN 
1948-2124
History 
  • Received December 16, 2015
  • Accepted April 18, 2016
  • Published online June 20, 2016.

Article Versions

  • You are currently viewing a previous version of this article (June 20, 2016 - 13:19).
  • View the most recent version of this article
Copyright & Usage 
Copyright © 2016, Parenteral Drug Association

Author Information

  1. Tobias Werk1,5 (tobias.werk{at}roche.com),
  2. Imke Sonja Ludwig1 (imke_sonja.ludwig{at}roche.com),
  3. Hanns-Christian Mahler2,
  4. Joerg Luemkemann1,
  5. Joerg Huwyler3 and
  6. Mathias Hafner4
  1. 1 F. Hoffmann-La Roche Ltd;
  2. 2 Lonza AG;
  3. 3 University of Basel;
  4. 4 University of Heidelberg
  1. ↵* Corresponding author; email: tobias.werk{at}roche.com

Cited By...

  • 8 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Mechanisms by which crystalline mannitol improves the reconstitution time of high concentration lyophilized protein formulations
    Shreya S. Kulkarni, Raj Suryanarayanan, Joseph V. Rinella, Robin H. Bogner
    European Journal of Pharmaceutics and Biopharmaceutics 2018 131
  • Toward a Point-of-Need Bioluminescence-Based Immunoassay Utilizing a Complete Shelf-Stable Reagent
    Mary P. Hall, Virginia A. Kincaid, Emily A. Jost, Thomas P. Smith, Robin Hurst, Stuart K. Forsyth, Connor Fitzgerald, Valerie T. Ressler, Kris Zimmermann, Dan Lazar, Monika G. Wood, Keith V. Wood, Thomas A. Kirkland, Lance P. Encell, Thomas Machleidt, Melanie L. Dart
    Analytical Chemistry 2021 93 12
  • Key factors governing the reconstitution time of high concentration lyophilized protein formulations
    Shreya S. Kulkarni, Sajal M. Patel, Raj Suryanarayanan, Joseph V. Rinella, Robin H. Bogner
    European Journal of Pharmaceutics and Biopharmaceutics 2021 165
  • Opportunities in an Evolving Pharmaceutical Development Landscape: Product Differentiation of Biopharmaceutical Drug Products
    Andrea Allmendinger
    Pharmaceutical Research 2021 38 5
  • Prefilled dual chamber devices (DCDs) – Promising high-quality and convenient drug delivery system
    Rahul G. Ingle, Wei-Jie Fang
    International Journal of Pharmaceutics 2021 597
  • Multiple approaches to reduce reconstitution time of lyophilized drug products with high protein concentration
    Xiaozhang Zhang, Ningning Zhou, Chunsheng Yang, Zhaowei Jin, Jeremy Guo
    Antibody Therapeutics 2024 7 1
  • Principles and Practices of Lyophilization in Product Development and Manufacturing
    Andrea Allmendinger, Christina Häuser, Lokesh Kumar, Ilona Vollrath
    2023 59
  • Standardization of the Reconstitution Procedure of Protein Lyophilizates as a Key Parameter to Control Product Stability
    Kerstin Traub-Hoffmann, Britta Furtmann, Lars Laber, Sarah Helm, Claus Geiger, Till Bussemer
    Journal of Pharmaceutical Sciences 2020 109 1
Next
Back to top

In This Issue

PDA Journal of Pharmaceutical Science and Technology: 79 (1)
PDA Journal of Pharmaceutical Science and Technology
Vol. 79, Issue 1
January/February 2025
  • Table of Contents
  • Index by Author
  • Complete Issue (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The effect of formulation, process and method variables on the reconstitution time in dual chamber syringes
(Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology
(Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
6 + 4 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
The effect of formulation, process and method variables on the reconstitution time in dual chamber syringes
Tobias Werk, Imke Sonja Ludwig, Hanns-Christian Mahler, Joerg Luemkemann, Joerg Huwyler, Mathias Hafner
PDA Journal of Pharmaceutical Science and Technology Jun 2016, pdajpst.2015.006387; DOI: 10.5731/pdajpst.2015.006387

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The effect of formulation, process and method variables on the reconstitution time in dual chamber syringes
Tobias Werk, Imke Sonja Ludwig, Hanns-Christian Mahler, Joerg Luemkemann, Joerg Huwyler, Mathias Hafner
PDA Journal of Pharmaceutical Science and Technology Jun 2016, pdajpst.2015.006387; DOI: 10.5731/pdajpst.2015.006387
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • A proof-of-concept study on a universal standard kit to evaluate the risks of inspectors for their foundational ability of visual inspection of injectable drug products
  • Understanding Alignment in the Execution of Extractable Screening Studies Between Laboratories: Results of the ELSIE Lab Practices Sub-Team Industry Surveys
  • Definition of Particle Visibility Threshold in Parenteral Drug Products—Towards Standardization of Visual Inspection Operator Qualification
Show more Research

Similar Articles

Keywords

  • Aseptic processing
  • dual chamber syringe
  • reconstitution

Readers

  • About
  • Table of Content Alerts/Other Alerts
  • Subscriptions
  • Terms of Use
  • Contact Editors

Author/Reviewer Information

  • Author Resources
  • Submit Manuscript
  • Reviewers
  • Contact Editors

Parenteral Drug Association, Inc.

  • About
  • Advertising/Sponsorships
  • Events
  • PDA Bookstore
  • Press Releases

© 2025 PDA Journal of Pharmaceutical Science and Technology Print ISSN: 1079-7440  Digital ISSN: 1948-2124

Powered by HighWire